TALICIA FDA approval date

The FDA approved TALICIA on 1 Nov 2019.

FDA approval date
1 Nov 2019

Drug identity has not yet been verified against registry records

Also recorded as AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-11-01DayTALICIAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA213004", "applicant_as_listed_by_fda": "TALICIA HOLDINGS", "brand_names": ["TALICIA"], "active_ingredients": ["AMOXICILLIN", "OMEPRAZOLE MAGNESIUM", "RIFABUTIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20191101", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026